Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus
- PMID: 28672387
- DOI: 10.7326/L17-0234
Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus
Comment on
-
Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus.Ann Intern Med. 2017 Jul 4;167(1):73-74. doi: 10.7326/L17-0231. Ann Intern Med. 2017. PMID: 28672385 No abstract available.
Similar articles
-
Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus.Ann Intern Med. 2017 Jul 4;167(1):74-75. doi: 10.7326/L17-0233. Ann Intern Med. 2017. PMID: 28672386 No abstract available.
-
Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus.Ann Intern Med. 2017 Jul 4;167(1):73-74. doi: 10.7326/L17-0231. Ann Intern Med. 2017. PMID: 28672385 No abstract available.
-
Oral pharmacologic treatment of type 2 diabetes mellitus.Ann Intern Med. 2012 Jul 3;157(1):76; author reply 76-7. doi: 10.7326/0003-4819-157-1-201207030-00018. Ann Intern Med. 2012. PMID: 22751769 No abstract available.
-
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.Pharmacoeconomics. 2004;22(6):389-411. doi: 10.2165/00019053-200422060-00005. Pharmacoeconomics. 2004. PMID: 15099124 Review.
-
Combination therapy of oral hypoglycemic agents in patients with type 2 diabetes mellitus.Korean J Intern Med. 2017 Nov;32(6):974-983. doi: 10.3904/kjim.2017.354. Epub 2017 Oct 27. Korean J Intern Med. 2017. PMID: 29096431 Free PMC article. Review.
Cited by
-
Yogliptin monotherapy in type 2 diabetes: A 12-week randomized, double-blind, placebo-controlled phase II study.J Diabetes. 2022 Dec;14(12):822-830. doi: 10.1111/1753-0407.13337. Epub 2022 Dec 14. J Diabetes. 2022. PMID: 36515221 Free PMC article. Clinical Trial.
-
RELATIONSHIP BETWEEN OBSTRUCTIVE SLEEP APNEA AND THE PRESENCE AND SEVERITY OF DIABETIC RETINOPATHY.Retina. 2018 Nov;38(11):2197-2206. doi: 10.1097/IAE.0000000000001848. Retina. 2018. PMID: 28937527 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical